FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bishoy Rizkalla

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Darrell H G Crawford; Gregory J Dore; Philippa S Marks; Geoffrey McCaughan; William Rawlinson; Bishoy Rizkalla; Stuart K Roberts; William Sievert; Martin Weltman; Motoko Yoshihara; Wendy S C Cheng
Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients.
Wendy S C Cheng; Stuart K Roberts; Geoffrey McCaughan; William Sievert; Martin Weltman; Darrell Crawford; William Rawlinson; Philippa S Marks; James Thommes; Bishoy Rizkalla; Motoko Yoshihara; Gregory J Dore
Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
Stuart K Roberts; Martin Weltman; Darrell H G Crawford; Geoffrey W McCaughan; William Sievert; Wendy S Cheng; William Rawlinson; Paul V Desmond; Phillipa S Marks; Motoko Yoshihara; Bishoy Rizkalla; Jean K Depamphilis; Gregory J Dore
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bishoy Rizkalla (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Darrell H G Crawford; Gregory J Dore; Philippa S Marks; Geoffrey McCaughan; William Rawlinson; Bishoy Rizkalla; Stuart K Roberts; William Sievert; Martin Weltman; Motoko Yoshihara; Wendy S C Cheng
Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients.
Antiviral therapy 2012;17(5):849-54.
2010: Wendy S C Cheng; Stuart K Roberts; Geoffrey McCaughan; William Sievert; Martin Weltman; Darrell Crawford; William Rawlinson; Philippa S Marks; James Thommes; Bishoy Rizkalla; Motoko Yoshihara; Gregory J Dore
Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
Journal of hepatology 2010;53(4):616-23.
2009: Stuart K Roberts; Martin Weltman; Darrell H G Crawford; Geoffrey W McCaughan; William Sievert; Wendy S Cheng; William Rawlinson; Paul V Desmond; Phillipa S Marks; Motoko Yoshihara; Bishoy Rizkalla; Jean K Depamphilis; Gregory J Dore
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.
Hepatology (Baltimore, Md.) 2009;50(4):1045-55.
2005: Bishoy Rizkalla; Josephine M Forbes; Zemin Cao; Geoffrey Boner; Mark E Cooper
Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system.
Journal of hypertension 2005;23(1):153-64.
2004: Vicki Thallas; Carsten Lindschau; Bishoy Rizkalla; Leon A Bach; Geoffrey Boner; Matthias Meier; Hermann Haller; Mark E Cooper; Josephine M Forbes
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.
Diabetes 2004;53(11):2921-30.
2004: Rodney Dilley; Bishoy Rizkalla; John F Bertram
Cardiovascular hypertrophy in one-kidney, one-clip renal hypertension is resistant to heparin.
Journal of hypertension 2004;22(4):767-74.
2003: Bishoy Rizkalla; Josephine M Forbes; Mark E Cooper; Zemin Cao
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors.
Journal of the American Society of Nephrology : JASN 2003;14(12):3061-71.
2003: Stella Sarlos; Bishoy Rizkalla; Christina Moravski; Zemin Cao; Mark E Cooper; Jennifer L Wilkinson-Berka
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.
The American journal of pathology 2003;163(3):879-87.
1999: Mark E Cooper; D Vranes; S Youssef; Steven A Stacker; Alison J Cox; Bishoy Rizkalla; David Casley; Leon A Bach; Darren J Kelly; Richard E Gilbert
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
Diabetes 1999;48(11):2229-39.